Similarly, if patients were newly prescribed a different GLP-1 receptor agonist during semaglutide follow-up, only earlier BMI measurements were used
Focused on promoting health, enhancing performance, and extending longevity, our goal is to provide everything necessary for equine well-being
The quality of life improvements - fewer hospitalizations, reduced overdoses, less suicidal ideation - represent genuine harm reduction beyond any metabolic benefits
In its announcement, which came Friday afternoon, the FDA noted that safety and efficacy of Wegovy in the new indication were based on a trial comprising 17,600 patients randomized to receive either Novos drug or placebo, as well as standard medical treatment and lifestyle counseling
Kishimoto M